The mast cell and inflammation

Australian and New Zealand Journal of Medicine

Volumn 26, Issue 2, 1996, Pages 216-225

  McNeil, H P ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; CYTOKINE;

ALLERGY; HUMAN; INFLAMMATION; MAST CELL; PATHOPHYSIOLOGY; REVIEW;

EID: 0029955572     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1996.tb00887.x     Document Type: Review

References (67)

1. Wasserman SI. The mast cell and synovial inflammation: or, what's a nice cell like you doing in a joint like this? Arthritis Rheum 1984; 27: 841-4.
2. Ehrlich P. Beitrage zur Theorie und Praxis der histologischer Farbung. (Ph.D. thesis. Leipzig, Germany: University of Leipzig, 1878.)
3. Galli SJ. New insights into 'the riddle of the mast cells': microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990; 62: 5-33.
4. Fodinger M, Fritsch G, Winkler K et al. Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. Blood 1994; 84: 2954-9.
5. + colony-forming cell. J Immunol 1993; 151: 4221-7.
6. Irani A-MA, Nilsson G, Miettinen U et al. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 1992; 80: 3009-21.
7. Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Ann Rev Immunol 1989; 7: 59-76.
8. McNeil HP, Austen KF. Biology of the mast cell. In: 'Samter's' Immunological diseases. 5th edition. Boston: Little Brown & Co, 1995, Chap 13. 185-204.
9. Sillaber C, Sperr WR, Agis H, Spanblochl E, Lechner K, Valent P. Inhibition of stem cell factor-dependent formation of human mast cells by interleukin-3 and interleukin-4. International Archives of Allergy and Immunology. 1994; 105: 264-8.
10. Nilsson G, Miettinen U, Ishizaka T, Ashman LK, Irani A-M, Schwartz LB. Interleukin-4 inhibits the expression of kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells. Blood 1994; 84: 1519-27.
11. Denburg JA. Basophil and mast cell lineages in vitro and in vivo. Blood 1992; 79: 846-60.
12. Craig SS, Schechter NM, Schwartz LB. Ultrastructural analysis of human T and TC mast cells identified by immunoelectron microscopy. Lab Invest 1988; 58: 682-91.
13. Weidner N, Austen KF. Evidence for morphologic diversity of human mast cells. An ultrastructural study of mast cells from multiple body sites. Lab Invest 1990; 63: 63-72.
14. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA. 1986; 83: 4464-8.
15. Weidner N, Austen KF. Ultrastructural and immunohistochemical characterization of normal mast cells at multiple body sites. J Invest Dermatol 1991; 96: 26S-31S.
16. Cohan VL, Massey WA, Gittlen SD et al. The heterogeneity of human histamine containing cells. In: Mast cell and basophil differentiation and function in health and disease. New York: Raven Press, 1989, 149-59.
17. McNeil HP, Austen KF. Cytokine regulation of mouse mast cell-specific protease genes. In: 'Advances in prostaglandin, thromboxane and leukotriene research', Volume 22. New York: Raven Press, 1994, 71-81.
18. Massey WA, Guo C-B, Dvorak AM et al. Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacology. J Immunol 1991; 147: 1621-7.
19. Ghildyal N, McNeil HP, Gurish MF, Austen KF, Stevens RL. Transcriptional regulation of the mucosal mast cell-specific protease gene, MMCP-2, by interleukin 10 and interleukin 3. J Biol Chem 1992; 267: 8473-7.
20. Gurish MF, Ghildyal N, McNeil HP, Austen KF, Gillis S, Stevens RL. Differential expression of secretory granule proteases in mouse mast cells exposed to interleukin-3 and c-kit ligand. J Exp Med 1992; 175: 1003-12.
21. Takagi M, Nakahata T, Kubo T et al. Stimulation of mouse connective tissue-type mast cells by hemopoietic stem cell factor, a ligand for the c-kit receptor. J Immunol 1992; 148: 3446-53.
22. Craig SS, Schechter NM, Schwartz LB. Ultrastructural analysis of maturing T and TC mast cells in situ. Lab Invest 1989; 60: 147-57.
23. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992; 10: 411-52.
24. Falus A, Meretey K. Histamine: an early messenger in inflammatory and immune reactions. Immunology Today. 1992; 13: 154-6.
25. 3H]diisopropyl fluorophosphate-binding proteins are exocytosed from activated mouse bone marrow-derived mast cells. J Biol Chem 1986; 261: 15017-21.
26. Goldstein SM, Leong J, Schwartz LB, Cooke D. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. J Immunol 1992; 148: 2475-82.
27. Schechter NM, Wang ZM, Blacher RW, Lessin SR, Lazarus GS, Rubin H. Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions. J Immunol 1994; 152: 4062-9.
28. Sali A, Matsumoto R, McNeil HP, Karplus M, Stevens RL. Three-dimensional models of four mast cell chymases. Identification of proteoglycan-binding domains and protease-specific antigenic epitopes. J Biol Chem 1993; 268: 9023-34.
29. Johnson DA, Barton GJ. Mast cell tryptases: examination of unusual characteristics by multiple sequence alignment and molecular modelling. Protein Science 1992; 1: 370-7.
30. DuBuske L, Austen KF, Czop J, Stevens RL. Granule-associated serine neutral proteases of the mouse bone marrow-derived mast cell that degrade fibronectin. J Immunol 1984; 133: 1535-41.
31. Stevens RL, Somerville LL, Sewell D et al. Serosal mast cells maintain their viability and promote the metabolism of cartilage proteoglycans when cocultured with chondrocytes. Arthritis Rheum 1992; 35: 325-35.
32. Gruber BL, Marchese MJ, Suzuki K et al. Synovial procollagenase activation by human mast cell tryptase: dependence upon matrix metalloproteinase 3 activation. J Clin Invest 1989; 84: 1657-62.
33. Lees M, Taylor DJ, Woolley DE. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur J Biochem. 1994; 223: 171-7.
34. Caughey, GH. Roles of mast cell tryptase and chymase in airway function. Am J Physiol 1989; 257: L39-L46.
35. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. N Engl J. Med 1990; 323: 645-55.
36. 4 action on endothelium mediates augmented neutrophil/endothelial adhesion. Proc Natl Acad Sci USA 1984; 84: 2191-3.
37. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol. Today. 1990; 11: 458-64.
38. Bradding P, Feather IH, Wilson S et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. J Immunol 1993; 151: 3853-65.
39. Bradding P, Roberts JA, Britten KM et al. Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Resp Cell Mol Biol 1994; 10: 471-80.
40. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor-α, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991; 88: 4220-4.
41. Moller A, Lippert U, Lessmann D et al. Human mast cells produce IL-8. J Immunol 1993; 151: 3261-6.
42. McKay DM, Bienenstock J. The interaction between mast cells and nerves in the gastrointestinal tract. Immunology Today 1994; 15: 533-8.
43. Alam R, Kumar D, Anderson-Walters D, Forsythe PA. Macrophage inflammatory protein-1α and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J Immunol 1994; 152: 1298-303.
44. Yamamura H, Nabe T, Kohno S, Ohata K. Endothelin-1, one of the most potent histamine releasers in mouse peritoneal mast cells. Eur J Pharmacol 1994; 265: 9-15.
45. Johnson AR, Hugli TE, Muller-Eberhard HJ. Release of histamine from rat mast cells by complement peptides C3a and C5a. Immunology 1975; 28: 1067-72.
46. Irani AA, Schwartz LB. Mast cell heterogeneity. Clin Exp Allergy 1989; 19: 143-55.
47. Malaviya R, Ross E, MacGregor JI et al. Mast cell phagocytosis of FimH-expressing enterobacteria. J Immunol 1994; 152: 1907-14.
48. Galli SJ. New concepts about the mast cell. N Engl J Med 1993; 328: 257-65.
49. Frandji P, Oskeritzian C, Cacaraci F et al. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J Immunol 1993; 151: 6318-28.
50. 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin: demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J Immunol 1987; 139: 2605-14.
51. Malone DG, Metcalfe DD. Demonstration and characterization of a transient arthritis in rats following sensitization of synovial mast cells with antigen-specific IgE and parenteral challenge with specific antigen. Arthritis Rheum 1988; 31: 1063-7.
52. Wershil BK, Wang Z-S, Gordon JR, Galli SJ. Recruitment of neutrophils during IgE-dependent cutaneous late phase responses in the mouse is mast cell-dependent: partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin Invest 1991; 87: 446-53.
53. Zhang Y, Ramos BF, Jakschik BA. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 1992; 258: 1957-9.
54. Ramos BF, Zhang Y, Jakschik BA. Neutrophil elicitation in the reverse passive Arthus reaction. Complement-dependent and -independent mast cell involvement. J Immunol 1994; 152: 1380-4.
55. Grant JA, Alam R, Lett-Brown MA. Histamine releasing factors and inhibitors: historical perspectives and possible implications in human illness. J Allergy Clin Immunol 1991; 88: 683-93.
56. Kubes P, Kanwar S. Histamine induces leukocyte rolling in post-capillary venules. A P-selectin-mediated event. J Immunol 1994; 152: 3570-7.
57. Gaboury JP, Johnston B, Niu X-F, Kubes P. Mechanisms underlying acute mast cell-induced leukocyte rolling and adhesion in vivo. J Immunol 1995; 154: 804-13.
58. Ying S, Durham SR, Jacobson MR et al. T lymphocytes and mast cells express messenger RNA for interleukin-4 in nasal mucosa in allergen-induced rhinitis. Immunology 1994; 82: 200-6.
59. Gauchat J-F, Henchoz S, Mazzei G et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993; 365: 340-3.
60. Malone DG, Wilder RL, Saavedra-Delgado AM, Metcalfe DD. Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lymphocytic infiltration and modulation by anti-inflammatory therapy. Arthritis Rheum 1987; 30: 130-7.
61. Irani AA, Craig SS, DeBlois G, Elson CO, Schechter NM, Schwartz LB. Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J Immuno 1987; 138: 4381-6.
62. Lavker RM, Schechter NM. Cutaneous mast cell depletion results from topical corticosteroid usage. J Immunol 1985; 135: 2368-73.
63. Okuda M, Sakaguchi K, Otsuka H. Intranasal beclomethasone: Mode of action in nasal allergy. Ann Allergy 1983; 50: 116-20.
64. Goldsmith P, McGarity B, Walls AF, Church MK, Millward-Sadler GH, Robertson DA. Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease. Dig Dis Sci 1990; 35: 1409-13.
65. Soda K, Kawabori S, Perdue MH, Bienenstock J. Macrophage engulfment of mucosal mast cells in rats treated with dexamethasone. Gastroenterology 1991; 100: 929-37.
66. Kaye RE, Fruman DA, Bierer BE et al. Effects of cyclosporin A and FK506 on Fee receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12. Proc Natl Acad Sci USA 1992; 89: 8542-6.
67. Wershil BK, Furuta GT, Lavigne JA, Choudhury AR, Wang ZS, Galli SJ. Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades - multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse. J Immunol 1995; 154: 1391-8.